Copper, iron and zinc in Alzheimer's disease senile plaques

M.A Lovell; J.D Robertson; W.J Teesdale; J.L Campbell; W.R Markesbery

doi:10.1016/s0022-510x(98)00092-6

journal article Jun 01, 1998

Copper, iron and zinc in Alzheimer's disease senile plaques

M.A Lovell J.D Robertson W.J Teesdale J.L Campbell W.R Markesbery

Journal of the Neurological Sciences Vol. 158 No. 1 pp. 47-52 · Elsevier BV

View at Publisher Save 10.1016/s0022-510x(98)00092-6

Topics

No keywords indexed for this article. Browse by subject →

References

69

[1]

Assaf "Release of endogenous Zn2+ from brain tissue during activity" Nature (1984) 10.1038/308734a0

[2]

Ashkenazi "Nutritional iron and dopamine binding sites in the rat brain" Pharmacol. Biomed. Behav. (1982) 10.1016/0091-3057(82)90509-3

[3]

Atwood CS, Moir RD, Huang X, Tanzi RE, Bush AI. Cerebral zinc metabolism in Alzheimer's disease. In: Waso W, Tanzi RE, editors. Molecular mechanisms of dementia. Totowa NJ: Humana Press, 1997:225–37. 10.1007/978-1-59259-471-9_14

[4]

Backstrom "Characterization of neutral proteinases from Alzheimer affected and control brain specimens: identification of calcium dependent metalloproteinases from the hippocampus" J. Neurochem. (1992) 10.1111/j.1471-4159.1992.tb09352.x

[5]

Balazs "Evidence of an oxidative challenge in the Alzheimer's brain" Neurochem. Res. (1994) 10.1007/bf00965146

[6]

Ben-Shachar "Dopamine D2 receptor modulation by brain non-haem iron" Br J Pharmacol (1987)

[7]

Bush "A novel zinc (II) binding site modulates the function of the βA4 amyloid protein precursor of Alzheimer's disease" J. Biol. Chem. (1993) 10.1016/s0021-9258(19)85394-2

[8]

Bush "Rapid induction of Alzheimer Aβ amyloid formation by zinc" Science (1994) 10.1126/science.8073293

[9]

Bush "The amyloid β-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily" J. Biol. Chem. (1994) 10.1016/s0021-9258(18)47062-7

[10]

Bush "Zinc and Alzheimer's disease" Science (1995) 10.1126/science.268.5219.1921

[11]

Candy JM, Edwardson JA, Klinowski J, Oakley AE, Perry EK, Perry RH. Colocalization of aluminum and silicon in senile plaques: Implications for the neurochemical pathology of Alzheimer's disease. In: Traver J, Gispen GH, editors. Senile dementia of the Alzheimer's type. Berlin: Springer-Verlag, 1985:185–97. 10.1007/978-3-642-70644-8_15

[12]

Candy "Aluminosilicates and senile plaque formation in Alzheimer's disease" Lancet (1986) 10.1016/s0140-6736(86)92319-6

[13]

Connor "A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains" J Neurosci Res (1992) 10.1002/jnr.490310111

[14]

Connor "Cellular management of iron in the brain" J Neurol Sci (1995) 10.1016/0022-510x(95)00206-h

[15]

Connor "Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease" J Neurosci Res (1992) 10.1002/jnr.490310214

[16]

Corrigan "Hippocampal tin, aluminum and zinc in Alzheimer's disease" Biometals (1993) 10.1007/bf00205853

[17]

Crapper "Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration" Science (1973) 10.1126/science.180.4085.511

[18]

Crapper "Aluminum, neurofibrillary degeneration and Alzheimer's disease" Brain (1976) 10.1093/brain/99.1.67

[19]

Diebel "Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress" J. Neurol. Sci. (1996) 10.1016/s0022-510x(96)00203-1

[20]

Ehmann "Brain trace elements in Alzheimer's disease" Neurotoxicology (1986)

[21]

el Lozy M, Herreva MG, Latham MC, McGrady RB, McCann MB, Stare FJ. Nutrients. In: Nutrition. Kalamazoo MI: Upjohn, 1980:51–85.

[22]

Evans "Prevalence of Alzheimer's disease in a community population of older persons" JAMA (1989) 10.1001/jama.262.18.2551

[23]

Good "Selective accumulation of aluminum and iron in neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study" Ann. Neurol. (1992) 10.1002/ana.410310310

[24]

Goodman "Alzheimer's disease: A clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis" J. Nerv. Ment. Dis. (1953) 10.1097/00005053-195308000-00001

[25]

Grundke-Iqbal "Ferritin is a component of neuritic (senile) plaques in Alzheimer dementia" Acta Neuropathol. (1990) 10.1007/bf00334497

[26]

Halliwell "Oxygen radicals as key mediators in neurological disease: Fact or fiction?" Ann. Neurol. (1992) 10.1002/ana.410320704

[27]

Harman "Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer's type" Age (1993) 10.1007/bf02436127

[28]

Hensley "A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevence to Alzheimer's disease" Proc. Natl. Acad. Sci. USA (1994) 10.1073/pnas.91.8.3270

[29]

Hensley "Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation" J. Neurochem. (1995) 10.1046/j.1471-4159.1995.65052146.x

[30]

Hershey "Cerebrospinal fluid trace element content in dementia: clinical, radiologic and pathologic correlations" Neurology (1983) 10.1212/wnl.33.10.1350

[31]

Hess Chronische Bleivergiftung. Praxis (1974)

[32]

Howell "Stimulation-induced uptake and release of zinc in hippocampal slices" Nature (1984) 10.1038/308736a0

[33]

Johansson SAE, Campbell JL. PIXE: A novel technique for elemental analysis. New York: John Wiley and Sons, 1988.

[34]

Khachaturian "Diagnosis of Alzheimer's disease" Arch. Neurol. (1985) 10.1001/archneur.1985.04060100083029

[35]

Kemp "Multi-element analysis of the rat hippocampus by proton induced X-ray emission spectroscopy (phosphorus, sulphur, chlorine, potassium, calcium, iron, zinc, copper, lead, bromine, and rubidium)" Histochemistry (1979) 10.1007/bf00495664

[36]

Kromer-Vogt "Pathologic alterations in the amygdala in Alzheimer's disease" Neuroscience (1990) 10.1016/0306-4522(90)90408-v

[37]

Landsberg "Absence of aluminum in neuritic plaque cores in Alzheimer's disease" Nature (1992) 10.1038/360065a0

[38]

Landsberg "Microanalysis of senile plaques using nuclear microscopy" J Geriatr. Psychiatry Neurol. (1993) 10.1177/089198879300600206

[39]

Levy-Lahad "Genetic factors in Alzheimer's disease: A review of recent advances" Ann. Neurol. (1996) 10.1002/ana.410400604

[40]

Lovell "Comparison of laser microprobe mass spectrometry (LMMS) and micro particle induced X-ray emission (micro-PIXE) for the analysis of senile plaques in AD: a preliminary study" J. Radioanal. Nucl. Chem. Articles (1995) 10.1007/bf02036467

[41]

Lui "Metals and the liver in Alzheimer's disease: an investigation of hepatic zinc, copper, cadmium and metallothionein" J. Am. Geriatr. Soc. (1990) 10.1111/j.1532-5415.1990.tb01421.x

[42]

Markesbery WR, Ehmann WD. Brain trace elements in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press, 1994:353–67.

[43]

Markesbery WR, Ehmann WD, Alauddin M, Hossain TIM. Brain trace element concentrations in aging. Neurobiol Aging 1984:19–28. 10.1016/0197-4580(84)90081-2

[44]

Markesbery "Oxidative stress hypothesis in Alzheimer's disease" Free Radic Biol Med (1997) 10.1016/s0891-5849(96)00629-6

[45]

Maxwell "Compensation schemes for peak-tailing uncertainties in PIXE spectra using the GUPIX code" Nucl. Instrum. Methods Phys. Res. (1994) 10.1016/0168-583x(94)95671-5

[46]

McKhann "Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease" Neurology (1984) 10.1212/wnl.34.7.939

[47]

Meccoci "Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease" Ann. Neurol. (1994) 10.1002/ana.410360510

[48]

Mirra "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease" Neurology (1991) 10.1212/wnl.41.4.479

[49]

Moretz "Microanalysis of Alzheimer's disease NFT and plaques" Env. Geochem. Health (1990) 10.1007/bf01734044

[50]

Multhaup "The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I)" Science (1996) 10.1126/science.271.5254.1406

Showing 50 of 69 references

Cited By

1,767

Toxic mechanisms of amyloid oligomers and therapeutic strategies

Magdalena I. Ivanova, Carmelo La Rosa · 2026

Protein Science

Mechanism of oxidative stress and neurotoxicity associated with heme and copper–Aβ relevant to Alzheimer's disease

Chinmay Dey, Madhuparna Roy · 2025

Chemical Society Reviews

Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

Michael Okafor, Peter Faller · 2025

Translational Neurodegeneration

Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer’s Disease

Mateen A. Khan · 2024

Pharmaceuticals

Iron Chelators and Alzheimer’s Disease Clinical Trials

Pravat K. Mandal, Joseph C. Maroon · 2024

Journal of Alzheimer’s Disease

Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities

Wei-Biao Zang, Hui-Ling Wei · 2024

European Journal of Medicinal Chemi...

Cu(II) Specifically Disassembles Insulin Amyloid Nanostructures via Direct Interaction with Cross-β Fibrils

Shikha Mittal, Kailash Prasad Prajapati · 2024

Nano Letters

Targeting cuproplasia and cuproptosis in cancer

Daolin Tang, Guido Kroemer · 2024

Nature Reviews Clinical Oncology

The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents

Geoffrey Canet, Charleine Zussy · 2023

Pharmacology & Therapeutics

Understanding Alzheimer’s Disease and its Metal Chelation Therapeutics: A Narrative Review

Ritik Thakur, Ritu Karwasra · 2023

Current Pharmaceutical Design

Astrocyte metabolism and signaling pathways in the CNS

Yong-Mei Zhang, Ying-bei Qi · 2023

Frontiers in Neuroscience

Structural and biochemical insights into Zn2+-bound EF-hand proteins, EFhd1 and EFhd2

Sang A Mun, Jongseo Park · 2023

IUCrJ

Stimuli-controllable iron oxide nanoparticle assemblies: Design, manipulation and bio-applications

Liang Ee Low, Hui Peng Lim · 2022

Journal of Controlled Release

Microglia and Alzheimer’s Disease

Stefania Merighi, Manuela Nigro · 2022

International Journal of Molecular...

Azo-Stilbene and Pyridine–Amine Hybrid Multifunctional Molecules to Target Metal-Mediated Neurotoxicity and Amyloid-β Aggregation in Alzheimer’s Disease

Monika Rana, Hong-Jun Cho · 2022

Inorganic Chemistry

Nutrient‐sensing amyloid metastasis

L.M.T.R. Lima, T. Sisnande · 2022

BioFactors

Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids

Dieter Willbold, Birgit Strodel · 2021

Chemical Reviews

The essential elements of Alzheimer’s disease

Peng Lei, Scott Ayton · 2021

Journal of Biological Chemistry

The molecular and cellular basis of copper dysregulation and its relationship with human pathologies

May T. Maung, Alyssa Carlson · 2021

The FASEB Journal

Bis(8‐hydroxyquinoline) Ligands: Exploring their Potential as Selective Copper‐Binding Agents for Alzheimer's Disease

Valentina Oliveri, Graziella Vecchio · 2021

European Journal of Inorganic Chemi...

Metrics

1,767

Citations

69

References

Details

Published: Jun 01, 1998
Vol/Issue: 158(1)
Pages: 47-52
License: View

Authors

Cite This Article

M.A Lovell, J.D Robertson, W.J Teesdale, et al. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. Journal of the Neurological Sciences, 158(1), 47-52. https://doi.org/10.1016/s0022-510x(98)00092-6

Copper, iron and zinc in Alzheimer's disease senile plaques

You May Also Like